IDiyas

For the Inventor, By the Inventor

Kenosha, WI, United States of America

David A Riley

USPTO Granted Patents = 15

 

Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 314(Granted Patents)


Location History:

  • Waukegan, IL (US) (1986)
  • Kenosha, WI (US) (1995 - 2003)

Company Filing History:

goldMedal14 out of 4,177 
 
Abbott Laboratories Corporation
 patents
silverMedal1 out of 1 
 
Mediver Ab
 patent

Years Active: 1986-2003

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 6627743 - 6-O-methylerythromycin A crystal form III (2003-09-30),
2. 6437106 - Process for preparing 6-o-substituted erythromycin derivatives (2002-08-20),
3. 6184376 - Synthesis of acyclic nucleoside derivatives (2001-02-06),
4. 5945405 - Crystal form O of clarithromycin (1999-08-31),
5. 5932774 - Processes for the preparation of D-chiro-inositol (1999-08-03),
6. 5919916 - 6-O-alkyl derivatives of erythronolide B (1999-07-06),
7. 5905134 - Process for the preparation of polyanhydrides (1999-05-18),
8. 5892008 - Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy (1999-04-06),
9. 5864023 - 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives (1999-01-26),
10. 5858986 - Crystal form I of clarithromycin (1999-01-12),
11. 5844105 - Preparation of crystal form II of clarithromycin (1998-12-01),
12. 5760198 - Process for preparation of 4'-deoxyerythromycins A and B (1998-06-02),
13. 5463142 - Method for the preparation of D-chiro-inositol (1995-10-31),
14. 4613590 - Amino D-manno-2-octulopyranosidonate containing compounds, (1986-09-23),
15. 4613589 - D-manno-2-octulosonic acid derivatives, pharmaceutical compositions and (1986-09-23),

Title: David A. Riley: Innovator in Erythromycin Derivatives

Introduction

David A. Riley is a prominent inventor based in Kenosha, Wisconsin, known for his significant contributions to the field of medicinal chemistry. With a total of 15 patents to his name, he has made remarkable advancements in the development of erythromycin derivatives.

Latest Patents

Among his latest patents is the invention of a novel 6-O-methylerythromycin A crystal form III. This invention relates to a unique crystal form, a process for preparing it, and methods for utilizing this crystal form to create a 6-O-methylerythromycin A crystal form II. Another notable patent involves a process for preparing 6-O-substituted erythromycin derivatives. This process includes reacting 2′-substituted and optionally 4′-substituted 9-oxime erythromycin derivatives with an alkylating agent in the presence of a palladium catalyst and phosphine. Additionally, it encompasses processes for preparing 6-O-substituted erythromycin ketolides using the palladium-catalyzed alkylation reaction.

Career Highlights

David has worked with esteemed companies such as Abbott Laboratories Corporation and Mediver AB, where he has applied his expertise in medicinal chemistry to develop innovative solutions in pharmaceuticals.

Collaborations

Throughout his career, David has collaborated with notable professionals in the field, including Jih-Hua Liu and Yi-Yin Ku, enhancing the impact of his research and inventions.

Conclusion

David A. Riley's contributions to the field of erythromycin derivatives exemplify his dedication to innovation in medicinal chemistry. His patents and collaborations reflect a commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…